These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12814851)

  • 1. Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.
    Jabs BE; Bartsch AJ; Pfuhlmann B
    Eur Psychiatry; 2003 Jun; 18(4):177-81. PubMed ID: 12814851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study.
    Jabs BE; Berg D; Merschdorf U; Bartsch AJ; Pfuhlmann B
    Neuropsychobiology; 2001; 44(4):183-6. PubMed ID: 11702018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.
    Berg D; Jabs B; Merschdorf U; Beckmann H; Becker G
    Biol Psychiatry; 2001 Sep; 50(6):463-7. PubMed ID: 11566164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics.
    Caligiuri MP; Lacro JP; Jeste DV
    J Clin Psychopharmacol; 1999 Aug; 19(4):322-8. PubMed ID: 10440459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Hoexter MQ; Teixeira MJ; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2013 Aug; 19(8):742-5. PubMed ID: 23680416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
    Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
    Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
    Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial sonography in movement disorders.
    Bartova P; Skoloudik D; Bar M; Ressner P; Hlustik P; Herzig R; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Dec; 152(2):251-8. PubMed ID: 19219216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C; Guidi M
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.
    Berg D; Becker G; Zeiler B; Tucha O; Hofmann E; Preier M; Benz P; Jost W; Reiners K; Lange KW
    Neurology; 1999 Sep; 53(5):1026-31. PubMed ID: 10496262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.